Complementary and Body-based Interventions for IBD

Speaker giving a presentation

Join us for our webinar to learn about the different types of complementary and body-based interventions that may be integrated with your IBD treatment plan. An expert gastroenterologist will discuss the potential risks and benefits of the natural therapies (e.g. herbal remedies, diet supplements, probiotics, curcumin) and body-based practices (e.g. acupuncture, chiropractic, yoga, exercise) for Crohn’s disease and ulcerative colitis. You will also learn about scientific evidence suggest on these interventions.

You will have the opportunity to ask your questions ahead of time when you register or live during the event. 

This event will be offered in English, with live simultaneous French interpretation.  

Please click here to register for the webinar on May 24, 2023 at 7:00pm ET. Can't attend live? Register for the webinar and we'll send you a link to the recording. Please submit your questions ahead of time using the registration form.


Dr. Adam Weizman (MD, FRCPC) is a gastroenterologist at Mount Sinai Hospital in Toronto, Ontario and an Associate Professor of Medicine at the University of Toronto.  He was the recipient of Crohn’s and Colitis Canada’s Physician of the Year Award in 2022. 

Dr. Weizman is the Medical Director of the Inflammatory Bowel Diseases Centre at Mount Sinai Hospital and Head of Quality and Patient Safety for the division of gastroenterology at Mount Sinai Hospital and the University Health Network. His research interests include healthcare quality and health outcomes, with a focus on IBD.

Event Details

Date: May 24, 2023

Time: 7:00 - 8:30 pm ET

Location  • 
Zoom (Virtual)
Category  •  edu

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest